Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3 Growth Companies Insiders Own With Earnings Growth Up To 90%

In This Article:

As global markets react to accelerating U.S. inflation and the potential for reciprocal tariffs, growth stocks have been outperforming their value counterparts, with major indices like the Nasdaq Composite nearing record highs. In this environment, companies with high insider ownership can be particularly appealing as they often signal confidence in future earnings potential; here we explore three such growth companies that boast impressive earnings growth rates of up to 90%.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3)

17.3%

22.8%

Seojin SystemLtd (KOSDAQ:A178320)

32.1%

39.9%

Clinuvel Pharmaceuticals (ASX:CUV)

10.4%

26.2%

SKS Technologies Group (ASX:SKS)

29.7%

24.8%

Propel Holdings (TSX:PRL)

36.5%

38.7%

CD Projekt (WSE:CDR)

29.7%

39.4%

On Holding (NYSE:ONON)

19.1%

29.9%

Pharma Mar (BME:PHM)

11.9%

45.4%

Elliptic Laboratories (OB:ELABS)

26.8%

121.1%

Fulin Precision (SZSE:300432)

13.6%

71%

Click here to see the full list of 1460 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

Nanjing Vazyme Biotech

Simply Wall St Growth Rating: ★★★★★☆

Overview: Nanjing Vazyme Biotech Co., Ltd provides technology solutions in life science, biomedicine, and in vitro diagnostics with a market cap of CN¥8.71 billion.

Operations: Nanjing Vazyme Biotech Co., Ltd generates revenue through its offerings in life science, biomedicine, and in vitro diagnostics.

Insider Ownership: 12.8%

Earnings Growth Forecast: 90% p.a.

Nanjing Vazyme Biotech is experiencing rapid growth, with earnings forecasted to increase by 90% annually, significantly outpacing the Chinese market. Revenue is also expected to grow at 23.7% per year. The company recently completed a share buyback program worth CNY 106 million, enhancing shareholder value. Despite these positives, the company's return on equity is projected to remain low at 7.3% in three years, which may impact overall financial performance quality.

SHSE:688105 Ownership Breakdown as at Feb 2025
SHSE:688105 Ownership Breakdown as at Feb 2025

Henan Shijia Photons Technology

Simply Wall St Growth Rating: ★★★★★☆

Overview: Henan Shijia Photons Technology Co., Ltd. operates in the photonics industry and has a market capitalization of approximately CN¥8.89 billion.

Operations: The company generates revenue of CN¥942.76 million from its Optical Networking Equipments segment.